Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA
about
Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexesEstablishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeletonThe Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrixComprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsThe cell cycle independence of HIV infections is not determined by known karyophilic viral elements.Structure of equine infectious anemia virus matrix protein.Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif proteinHEED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1Sequence alignment reveals possible MAPK docking motifs on HIV proteinsPhosphorylation at serines 216 and 221 is important for Drosophila HeT-A Gag protein stabilityHIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenonThree isoforms of cyclophilin A associated with human immunodeficiency virus type 1 were found by proteomics by using two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry.Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription.Evolutionary dynamics of HIV-induced subversion of the immune response.Phosphorylation and proteolytic cleavage of gag proteins in budded simian immunodeficiency virus.Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia.Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cellsTranslation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyproteinOpposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.Complementation of integrase function in HIV-1 virions.Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase.Efficient HIV-1 replication can occur in the absence of the viral matrix protein.Capsid is a dominant determinant of retrovirus infectivity in nondividing cells.Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein.Pokeweed antiviral protein increases HIV-1 particle infectivity by activating the cellular mitogen activated protein kinase pathway.The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles.Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear importMembrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways.Controversy regarding the secondary active water transport hypothesis.HIV infection of non-dividing cells: a divisive problem.The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages.Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral proteaseStructure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable.Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particlesBiological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.
P2860
Q24523667-DCC22BBC-3492-4262-BA2A-3977785F7CE6Q24562936-11017B6F-4F32-41D0-B4E8-A605C07D544BQ24647043-AAC9206E-8091-4886-9AA6-3E3D2D421F71Q24673997-A976D579-6109-4E5D-BFB7-09DD721DC097Q24678970-BAF9E271-9935-44C5-BFA5-9338DB3B72F2Q24816846-62F9279A-79B9-4FD6-8073-4A3DAA2E01F7Q27637386-C79D8C1F-8EDF-4B36-A2CC-094A8686F1A5Q28287061-353BD109-7258-4055-B519-FFDF24F94DB8Q28293190-B19AFCD1-826B-4961-B622-519DD66E22D1Q28472679-9F62D340-2026-42D6-800C-8E77A45B1E8CQ28533585-266669CF-057C-4BA7-BA25-131907D2562AQ30009553-1F38E395-FD68-44C8-9C46-A747D493FA09Q31107472-1B6785F1-0282-4881-ABBE-FDA87C5FF1F6Q33654155-8498B222-24A5-430E-A839-3BA0AD310317Q33683341-C3A86B3F-DD35-455B-AEC5-C0DF395CA111Q33781019-34DA6C54-B925-4D00-BBF4-118D41C94381Q33782781-EA0496AB-3769-4A61-81F2-88DF4B41F176Q33783434-1818D71B-6DF0-46AF-B08D-A94D035F30EAQ33811857-20FFA10A-5C9F-4CD7-B0B1-23DB46FB0241Q33814996-48308287-F4DD-431D-BC08-E3E19353A27EQ33851786-EB94ACEA-37F2-47EA-8B7B-2D5A4633C97EQ33866230-3FDA4736-D81C-4F55-B16D-F0D7CA9E4B16Q33887343-F70A3FBD-21B4-4786-939C-46FBE31C26E6Q33888794-880C7670-8A9F-46BA-9029-C53D2795B029Q33888825-0C163FA8-9016-4F8E-B287-42440CDC1961Q34152408-FD371A89-BC38-476A-A1E3-23DC25370653Q34211568-AE385967-C714-4893-930C-D86919D54968Q34260135-9628F247-508E-4F45-9E1C-D15726E45ABAQ34329950-A7E52DE4-A681-47B3-89FF-BE5A4AE94620Q34359748-1772169A-175F-494B-9A52-75C22B0ADEE1Q34435902-EF58809B-77EF-4615-8898-A508C230E5D9Q34485584-A2711C12-4496-441C-A0AC-EAB044B06F50Q35003136-02CF05E7-2090-4C5C-9B2C-E03EE3CC13C2Q35127406-9758B250-1C5E-42DA-854D-347B9900BEE0Q35741691-9A7EA544-B21F-4699-8C51-A5CD68C065F7Q35876343-E12CC410-E46B-4667-9E33-564296478342Q35882404-9FB6C996-7F01-4375-8E1E-E2E47ED2F3F5Q35882911-39A158B7-D58C-4169-BBE7-269D703BED50Q35887391-9CC4DAF2-9501-4F33-A240-BCF358A0E96FQ35887971-5E40C46D-82E7-4EC8-BF88-8004A07E50DD
P2860
Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@ast
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@en
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@nl
type
label
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@ast
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@en
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@nl
prefLabel
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@ast
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@en
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@nl
P2093
P2860
P356
P1476
Phosphorylation-dependent huma ...... nuclear targeting of viral DNA
@en
P2093
A G Bukrinskaya
A Ghorpade
M Stevenson
N K Heinzinger
T E Smithgall
P2860
P304
P356
10.1073/PNAS.93.1.367
P407
P577
1996-01-09T00:00:00Z